Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review.
Alroughani R, Inshasi J, Al Khawajah M, Ahmed SF, Al Malik Y, Alkhabouri J, Shatila A, Aljarallah S, Cupler EJ, Qureshi SA, Thakre M, Elhasin H, Ezzat A, Roushdy S. Alroughani R, et al. Among authors: alkhabouri j. Mult Scler J Exp Transl Clin. 2022 Mar 9;8(1):20552173221077185. doi: 10.1177/20552173221077185. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35284088 Free PMC article.
Safety and effectiveness of disease-modifying therapies after switching from natalizumab.
Zeineddine M, Al-Roughani R, Farouk Ahmed S, Khoury S, El-Ayoubi N, Al-Mahdawi A, Al-Khabouri J, Al-Asmi A, Chentouf A, Inshasi J, Gouider R, Mrabet S, Shalaby N, Massouh J, Mohamed Ramzy Hasan Mohamed F, Al-Hajje A, Salameh P, Dimassi H, Boumediene F, Yamout B. Zeineddine M, et al. Mult Scler. 2024 Jul;30(8):1026-1035. doi: 10.1177/13524585241261565. Epub 2024 Jul 26. Mult Scler. 2024. PMID: 39054846
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice.
Yamout B, Alroughani R, Inshasi J, Farouk S, Abdulla F, Al-Jarki NY, Alasmi A, Al Fahad S, Alkhabouri J, Al-Saffar K, Benedetti B, Canibano B, Deleu D, Hassan A, Sarathchandran P, Shatila A, Abouelnaga M, Thakre M, Szolics M, Boshra A. Yamout B, et al. Among authors: alkhabouri j. Neurol Ther. 2024 Oct;13(5):1321-1335. doi: 10.1007/s40120-024-00650-5. Epub 2024 Aug 3. Neurol Ther. 2024. PMID: 39097537 Free PMC article. Review.
Health-related Quality of Life of People with Multiple Sclerosis in Oman.
Natarajan J, Joseph MA, Al Asmi A, Matua GA, Al Khabouri J, Thanka AN, Al Balushi LD, Al Junaibi SM, Al Ismaili IS. Natarajan J, et al. Oman Med J. 2021 Nov 15;36(6):e318. doi: 10.5001/omj.2021.109. eCollection 2021 Nov. Oman Med J. 2021. PMID: 34804600 Free PMC article.
15 results